
This content was machine translated.
About 2NA FISH
Heterogeneous tumors contain few cancer cells (5-15%) and a variety of other cells, such as immune cells and fibroblasts. They are difficult to treat because current diagnostic methods put all these cell types into a “mixer” and then try to measure biomarkers in the resulting “smoothie.” 2NA FISH aims to revolutionize therapy decisions in cancer by developing the first technology for spatial RNA measurement (“spatial transcriptomics”) for clinical cancer diagnostics. By measuring up to 50 RNAs per single cell in spatial context, we can create more precise and predictable diagnoses for cancer therapy decisions.
More like this




